Table 2.
Subject’s demographic characteristics, distributions of CVRF, results of neurological, neuropsychological and neuroimaging examination in MCI group compared to the dementia group.
| N (%) | MCI | Dementia |
|---|---|---|
| Sex M:F | 26 (52):24 (48) | 29 (53):26 (47) |
| Age | 72 ± 8 | 75 ± 8 |
| Vascular component | 14 (29) | 14 (26) |
| EPS | 0 (0) | 17 (31) |
| Hypertension | 29 (62) | 31 (66) |
| Dyslipidemia | 16 (34) | 17 (36) |
| Diabetes mellitus | 12 (26) | 15 (32) |
| Smoking or ex-smoking | 10 (21) | 10 (21) |
| PVD | 2 (5) | 3 (7) |
| CAD | 4 (10) | 6 (14) |
| Prior stroke | 15 (37) | 11 (26) |
| Total cholesterol | 194 ± 40 | 190 ± 47 |
| HDL cholesterol | 50 ± 18 | 51 ± 21 |
| LDL cholesterol | 108 ± 63 | 103 ± 55 |
| Triglycerides♯ | 137 ± 100 | 171 ± 59 |
| HACHINSKI | 4 ± 3 | 4 ± 3 |
| GDS fast | 3 ± 1 | 4 ± 1 |
| MMSE♯ | 25 ± 4 | 21 ± 5 |
| UPDRS-III motorsub-scale♯ | 9 ± 9 | 37 ± 15* |
| WSTS♯ | 0.5 ± 0.4 | 0.7 ± 0.6 |
| 123I-FP-CIT SPECT decrease uptake♯ | 7 (21) | 14 (45) |
Numbers and % are presented for each group. ♯p < 0.05; *This refers only to PDD group.